MACK

Contrasting Merrimack Pharmaceuticals (NASDAQ:MACK) and Ardelyx (NASDAQ:ARDX)

Merrimack Pharmaceuticals Yesterday Reported Q1 EPS $0.020 Up From $(0.780) YoY

Merrimack Reports First Quarter 2020 Financial Results

US Stock Market Weekly Update March 30- April 3, 2020

Merrimack Pharma Reports Receipt Of $2.25M Related To Closing Of Asset Sale For Preclinical Nanoliposome Programs To Celator Pharma

Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update